Head-to-head · WeighScore
Bioverse vs Wisp
The verdict
Bioverse takes it — 65.2/100 to 64.4/100, but only just.
Bioverse grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bioverse (GoBioverse) offers compounded semaglutide and tirzepatide plus brand-name Ozempic, Wegovy, and Mounjaro. Wisp is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Bioverse | Wisp |
|---|---|---|
| WeighScore | 65.2/100 | 64.4/100 |
| Grade | C | C |
| Scorecard rank | #224 | #243 |
| Semaglutide | $129/mo (starting dose, compounded) | $225/mo (compounded oral) |
| Tirzepatide | $399/mo (starting dose, compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #224 · C
Strengths
- Wide formulary — compounded and brand-name semaglutide + tirzepatide plus metformin
- No membership, cancellation, doctor, or hidden fees
- Uses US-licensed, FDA-regulated pharmacies
Where it loses points
- No visible LegitScript or PCAB accreditation
- State availability not disclosed beyond 'a provider licensed in your state'
- Broader longevity platform (NAD+, B12, glutathione, hair, skincare, heart health) rather than GLP-1 focused
Graded #243 · C
Strengths
- Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
- LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
- Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary
Where it loses points
- The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
- The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
- Brand-name access is a prescription, not a dispensed product, so the drug cost is outside anything quoted here
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.